# Therapeutic Effect of Quetiapine on Methamphetamine-Induced Psychosis

> **NCT01939093** · PHASE4 · COMPLETED · sponsor: **Chulalongkorn University** · enrollment: 80 (actual)

## Conditions studied

- Methamphetamine-induced Psychosis

## Interventions

- **DRUG:** Diazepam
- **DIETARY_SUPPLEMENT:** Vitamin B1-6-12
- **DRUG:** Stugeron

## Key facts

- **NCT ID:** NCT01939093
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2013-09-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01939093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01939093, "Therapeutic Effect of Quetiapine on Methamphetamine-Induced Psychosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01939093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*